USFDA APPLICATION NUMBER - 21204 / DOSAGE - TABLET;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
NATEGLINIDE(UNII: 41X3PWK4O2) (NATEGLINIDE - UNII:41X3PWK4O2) | NATEGLINIDE | 60mg | 120mg |
Inactive Ingredients
Ingredient Name | Novartis Pharmaceuticals Corporation |
---|---|
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
CROSCARMELLOSE SODIUM(M28OL1HH48) | |
FERRIC OXIDE RED(1K09F3G675) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
HYPROMELLOSE 2208 (15000 MPA.S)(Z78RG6M2N2) | |
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
MAGNESIUM STEARATE(70097M6I30) | |
POLYETHYLENE GLYCOL(3WJQ0SDW1A) | |
POVIDONE(FZ989GH94E) | |
SILICON DIOXIDE(ETJ7Z6XBU4) | |
TALC(7SEV7J4R1U) | |
TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?